| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94ff2d78578d95d1e8d3a2233c76188d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/F28D20-023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-56 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q5-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C11D17-0039
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-8152
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J13-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09B67-0097
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-8164 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K23-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J13-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C11D17-00 |
| filingDate |
2010-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09e031f9e131186e5ef2b27e37c04558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98f2f733cf2254704ca0ca401d3aeef5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2880ffd1c0586139f01ccaea22641307
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b629f48d189c6c61e42fae47d281512 |
| publicationDate |
2013-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2563896-A2 |
| titleOfInvention |
Delivery particles |
| abstract |
The present application relates to encapsulated benefit agents, compositions comprising such encapsulated benefit agents and processes for making and using compositions comprising such encapsulated benefit agents. Such encapsulated benefit agents eliminate or minimize one or more of the drawbacks of current encapsulated benefit agents and thus provide formulators with additional perfume delivery opportunities. |
| priorityDate |
2010-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |